Octave Fund

Octave Fund is a smaller investment vehicle with website, LinkedIn and Crunchbase presence but no disclosed healthcare thesis, AI focus, stage preference, geography or check size in the source data. Founders should treat Octave as a generalist early-stage candidate where domain depth in healthcare cannot be assumed and the partner will likely lean on the founder to teach the market. Plausible check sizes for a firm of this profile sit in the $100K to $1.5M range as a participant in seed and pre-seed rounds, with constrained capacity to lead. Without published sector specialization, Octave is most likely a fit for digital health, B2B healthcare software, wellness and consumer-health businesses that translate cleanly to general SaaS or marketplace pattern-matching. Therapeutics, regulated devices, diagnostics and businesses leaning heavily on payer-contracting expertise are unlikely strong fits. Founders pitching healthcare AI should be prepared to lead the conversation on data access strategy, FDA risk if relevant, hospital sales cycles and reimbursement, since the firm is unlikely to come with that infrastructure. The realistic entry path is direct LinkedIn outreach to investment principals, ideally via a warm introduction. In a first conversation, founders should push for clarity on the fund’s check size band, current deployment pace, healthcare-specific exposure across the portfolio, lead-versus-participant posture, and any operational support beyond capital. Until more thesis signal becomes public, Octave belongs on a long list of potential round participants, not a target lead, for healthcare-specific raises.